FDA Update on Rare Breast Implant-Associated Type of Lymphoma FDA Update on Rare Breast Implant-Associated Type of Lymphoma
The FDA says breast implant-associated anaplastic large cell lymphoma is a rare T cell lymphoma that can develop after breast implants and provides guidance for clinicians.News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Plastic Surgery & Aesthetic Medicine News Alert Source Type: news
More News: Breast Augmentation | Cancer & Oncology | Hematology | Lymphoma | Plastic Surgery | T-cell Lymphoma